Business Standard

Bliss GVS Pharma consolidated net profit declines 25.28% in the September 2019 quarter

Image

Capital Market

Sales decline 8.02% to Rs 210.12 crore

Net profit of Bliss GVS Pharma declined 25.28% to Rs 30.98 crore in the quarter ended September 2019 as against Rs 41.46 crore during the previous quarter ended September 2018. Sales declined 8.02% to Rs 210.12 crore in the quarter ended September 2019 as against Rs 228.43 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales210.12228.43 -8 OPM %12.1218.18 -PBDT37.3165.13 -43 PBT33.8162.80 -46 NP30.9841.46 -25

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 12 2019 | 4:33 PM IST

Explore News